20077 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Nanoparticulate stabilized anti-hypertensive compositions
#1502PHARMACEUTICAL COMPOSITIONS
#1503PHARMACEUTICAL COMPOSITIONS OF ACTIVE SUBSTANCES DIFFICULT TO IMPROPERLY DIVERT FROM THEIR INTENDED ROUTE OF ADMINISTRATION
#1504Biodegradable material based on opened starch
#1505Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug
#1506IMATINIB COMPOSITIONS
#1507Process for preparing a particle comprising a biological molecule and a carrier polymer
#1508MULTICOMPARTMENT GRANULATE FORMULATIONS FOR ACTIVE SUBSTANCES
#1509COMBINATION OF A TRIPTAN AND AN NSAID
#1510ENHANCING SOLUBILITY AND DISSOLUTION RATE OF POORLY SOLUBLE DRUGS
#1511AEROSOL AND INJECTABLE FORMULATIONS OF NANOPARTICULATE BENZODIAZEPINE
#1512Manufacturing method of solid dispersion containing itraconazole
#1513NANOPARTICULATE ANTICONVULSANT AND IMMUNOSUPPRESSIVE COMPOSITIONS
#1514Snuff composition
#1515Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
#1516NANOPARTICULATE BICALUTAMIDE FORMULATIONS
#1517Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof
#1518TRANSDERMAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL, DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS
#1519Compositions and methods for drug delivery
#1520Amido derivatives-contained pharmaceutical composition
#1521Dry composition for oral ingestion and gel composition prepared just before use for oral ingestion
#1522Methods and compositions for treating post-operative pain comprising a local anesthetic
#1523SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#1524Systems and methods for delivery of drugs
#1525Water-soluble compositions of bioactive lipophilic compounds
#1526Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives
#1527NANOPARTICULATE TACROLIMUS FORMULATIONS
#1528Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same
#1529Method for formulating a controlled-release pharmaceutical formulation
#1530Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
#1531PHARMACEUTICAL COMPOSITION 271
#1532COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
#1533IONOPHORE ANTIBIOTIC FORMULATIONS
#1534EXTENDED RELEASE FORMULATION CONTAINING A WAX
#1535Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
#1536Mucoadhesive nanocomposite delivery system
#1537Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
#1538Novel Use of Zinc Gluconate for Treating Hydradenitis Suppurativa
#1539Itraconazole compositions with improved bioavailability
#1540Polymer formulations for delivery of bioactive materials
#1541APREPITANT COMPOSITIONS
#1542Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#1543Method For Preparing Nano-Scale Particle of Active Material
#1544Propellant-based nanoparticulate dry powder aerosols and method of making
#1545TRANSMUCOSAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL,DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS
#1546AQUEOUS SUSPENSIONS OF TMC278
#1547NANOPARTICULATE COMPOSITIONS OF IMMUNOSUPPRESSIVE AGENTS
#1548Odor control cellulose granules with quinone compounds
#1549IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF DOPAMINE AGONIST
#1550Pharmaceutical compositions
#1551INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
#1552Method for producing cosmetic and/or dermatological powder
#1553HEATED ROLLER COMPACTION PROCESS FOR MAKING PHARMACEUTICAL COMPOSITIONS
#1554Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
#1555DEFERASIROX PHARMACEUTICAL COMPOSITIONS
#1556Intermolecular Association Complex of a Carrier and of an Active Principle
#1557CRYOPRESERVATION OF CELLS USING CROSS-LINKED BIOACTIVE HYDROGEL MATRIX PARTICLES
#1558Microcrystalline cellulose compositions
#1559Rapidly disintegrating solid oral dosage form
#1560Grape Polyphenolics for Platelet and Bacterial Control
#1561PHARMACEUTICAL COMPOSITIONS
#1562Solid preparation having improved solubility
#1563Novel nifedipine compositions
#1564Combinations and modes of administration of therapeutic agents and combination therapy
#1565Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same
#1566METHODS AND COMPOSITIONS FOR CONTROLLING THE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS
#1567Tamper resistant lipid-based oral dosage form for opioid agonists
#1568Nanoparticulate compositions having lysozyme as a surface stabilizer
#1569Nanoparticulate beclomethasone dipropionate compositions
#1570Sustained-release formulation
#1571Ansamycin formulations and methods of use thereof
#1572EMBOLIZATION PARTICLES
#1573Ansamycin formulations and methods of use thereof
#1574EXTERNAL PREPARATION FOR IMPROVING COITAL FUNCTION
#1575Compositions and methods for delivery of poorly soluble drugs
#1576Cancer cell targeting using nanoparticles
#1577Thermo-kinetic mixing for pharmaceutical applications
#1578Novel nifedipine compositions
#1579Nanoparticulate benzothiophene formulations
#1580Isoflavone nanoparticles and use thereof
#1581DOSAGE FORMS WITH IMPROVED BIOAVAILABILITY
#1582UROLOGICAL DEVICES INCORPORATING COLLAGEN INHIBITORS
#1583Medical devices incorporating collagen inhibitors
#1584Chemoembolisation
#1585Methods of modifying amyloid β oligomers using non-peptidic compounds
#1586Production of dosage forms comprising a solid dispersion of a microcrystalline agent
#1587Compositions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory cytokines (alpha ketoalkanoic acid compound) for osteoporosis prevention, therapy and treatment of bone diseases
#1588SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST
#1589Compositions controlling pH range of release and/or release rate
#1590BIODEGRADABLE POLYPHOSPHORAMIDATES FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES
#1591Drug-delivery systems
#1592Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
#1593Nanoparticle dispersion containing lactam compound
#1594Immediate release dosage forms containing solid drug dispersions
#1595NANOPARTICULATE FORMULATIONS OF MODAFINIL
#1596Porous objects having immobilized encapsulated biomolecules
#1597IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF DOPAMINE AGONIST
#1598AMORPHOUS DRUG BEADS
#1599STABLE NANOSIZED AMORPHOUS DRUG
#1600Use of copolymers as solubilizers for slightly water-soluble compounds
#1601PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS
#1602Pharmaceutical compositions of adsorbates of amorphous drug
#1603Pharmaceutical composition for the treatment of acute disorders
#1604Amorphous aripiprazole and process for the preparation thereof
#1605Pharmaceutical microparticles
#1606NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1607Stabilized HME composition with small drug particles
#1608Methods of administering liquid droplet aerosols of nanoparticulate drugs
#1609Process for forming amorphous atorvastatin
#1610Delivery of drugs
#1611Pharmaceutical compositions with enhanced performance
#1612Pharmaceutical compositions for poorly soluble drugs
#1613Multiparticulates
#1614Process for milling poorly soluble drugs in presence of liquid propellants
#1615Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
#1616Chitosan-Based Particles
#1617Drug activation process and vibrational mill therefor
#1618Pharmaceutical Compositions Comprising Danazol
#1619Nanoparticulate anticonvulsant and immunosuppressive compositions
#1620Production method of drug containing composite particle
#1621Production of Solid Solutions Based on Poorly-Soluble Active Substances by a Short-Term Heating and Rapid Drying
#1622Coenzyme Q—containing composition
#1623AMINE POLYMER-MODIFIED NANOPARTICULATE CARRIERS
#1624Inhibiting surface enhanced crystallization of amorphous pharmaceuticals with ultrathin coatings
#1625Solid Dispersion of Hydrophobic Bioactive
#1626COMBINATION OF A NARCOTIC AND NON-NARCOTIC ANALGESIC
#1627NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1628Ansamycin formulations and methods of use thereof
#1629Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug
#1630Anti tumor compositions and methods of use
#1631Active Agent Formulations, Methods of Making, and Methods of Use
#1632Nanoparticulate compositions of angiogenesis inhibitors
#1633GAMMA RADIATION STERILIZED NANOPARTICULATE DOCETAXEL COMPOSITIONS AND METHODS OF MAKING SAME
#1634Composition Containing Micronutrients With Improved Anti-Oxidant Activity And The Use Thereof
#1635Amorphous Aprepitant Coprecipitates
#1636COMPOSITIONS CONTAINING CAPSINOIDS
#1637FINE PARTICLES OF POORLY WATER-SOLUBLE DRUG HAVING ENTERIC MATERIAL ADSORBED ON PARTICLE SURFACE
#1638Nanoparticulate statin formulations and novel statin combinations
#1639NANOPARTICULATE SORAFENIB FORMULATIONS
#1640Rapidly disintegrating solid oral dosage form
#1641Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1642Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers
#1643Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle Compositions
#1644Microparticles
#1645Carotenoids of enhanced bioavailability
#1646Solid composites of a calcium receptor-active compound
#1647INCREASED AMORPHOUS STABILITY OF POORLY WATER SOLUBLE DRUGS BY NANOSIZING
#1648SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
#1649Controlled release dosage form of tacrolimus
#1650Sirolimus formulation
#1651NANOPARTICULATE COMPOSITIONS OF IMMUNOSUPPRESSIVE AGENTS
#1652Nanoparticulate megestrol formulations
#1653Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
#1654Orally bioavailable CCI-779 formulations
#1655Amorphous solid dispersions
#1656Use of Amphiphilic Copolymers as Solubilising Agents
#1657Nanoparticulate tacrolimus formulations
#1658AMORPHOUS VALSARTAN AND THE PRODUCTION THEREOF
#1659Methods and compositions for deterring abuse of orally administered pharmaceutical products
#1660Low viscosity liquid dosage forms
#1661Pharmaceutical Composition for the Treatment or Prevention of Diseases Involving Obesity, Diabetes, Metabolic Syndrome, Neuro-Degenerative Diseases and Mitochondria Dyfunction Diseases
#1662Fine Particle and Pharmaceutical Preparation
#1663Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective Inhibitor
#1664Low temperature processes for making cyclic lipid implants for intraocular use
#1665Nanoparticulate fibrate formulations
#1666Topical Composition And Method Of Forming
#1667SIROLIMUS NANODISPERSION
#1668Urologic devices incorporating collagen inhibitors
#1669Medical devices incorporating collagen inhibitors
#1670Solid Dispersion Comprising Tacrolimus and Entericcoated Macromolecule
#1671Polyarylates for drug delivery and tissue engineering
#1672Aqueous Dispersions of a Mixture of Only Slightly Water Soluble or Water Insoluble Active Substances and a Single-Celled Protein Material
#1673Controlled release nanoparticulate compositions
#1674Finely divided composition containing poorly water soluble substance
#1675PROCESS FOR THE PREPARATION OF ADSORBATES OF VALSARTAN AND/OR ITS SOLVATES OR HYDRATES
#1676Water insoluble polymer matrix for drug delivery
#1677COMPOSITIONS COMPRISING NANOPARTICULATE NAPROXEN AND CONTROLLED RELEASE HYDROCODONE
#1678Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
#1679NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1680Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment
#1681COMPOSITIONS COMPRISING NANOPARTICULATE MELOXICAM AND CONTROLLED RELEASE HYDROCODONE
#1682Crystalline Maltitol Powder Less Prone to Consolidation and Method for Production Thereof
#1683Nanoparticulate fibrate formulations
#1684Keratin-Based Powders and Hydrogel for Pharmaceutical Applications
#1685Method of manufacturing anti-tumor and anti-viral compositions
#1686Water-soluble compositions of bioactive lipophilic compounds
#1687STABLE SOLID DOSAGE FORM CONTAINING AMORPHOUS CEFDITOREN PIVOXIL AND PROCESS FOR PREPARATION THEREOF
#1688Methods and compositions for treating proliferative diseases
#1689Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
#1690THE SURFACE TREATMENT OF NANOPARTICLES TO CONTROL INTERFACIAL PROPERTIES AND METHOD OF MANUFACTURE
#1691Pharmaceutical Compositions and Methods of Using Same
#1692Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
#1693NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1694Active Agent Formulations, Methods of Making, and Methods of Use
#1695Dry compositions
#1696Dry powder formulations of antihistamine for nasal administration
#1697Pharmaceutical compositions including nano-sized active agent
#1698Aqueous Dispersions of Low-Water Solubility or Water-Insoluble Active Substances and Dry Powders Produced Therefrom
#1699Amorphous aripiprazole and process for the preparation thereof
#1700Compositions and method for treating precancerous virus infection and prevention of cancer
#1701Bioadhesive nanoparticulate compositions having cationic surface stabilizers
#1702Nanoparticulate fibrate formulations
#1703Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
#1704Method for the production of porous particles
#1705SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN
#1706WATER-INSOLUBLE MEDICINE
#1707Nanoparticulate fibrate formulations
#1708Method of treating a plastic article
#1709Solid dispersion preparation
#1710Methods and compositions for deterring abuse of orally administered pharmaceutical products
#1711Nanoparticles for delivery of active agents
#1712Stabilization of chemical compounds using nanoparticulate formulations
#1713CYCLOSPORIN A COMPOSITIONS
#1714High Pressure Compaction For Pharmaceutical Formulations
#1715Pharmaceutical Compositions
#1716SOLID-STATE FORM OF CELECOXIB HAVING ENHANCED BIOAVAILABILITY
#1717Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof
#1718ANTIVIRAL COMPOSITIONS
#1719Simethicone solid oral dosage form
#1720External preparation for treating skin or mucosal injury caused by viral infection
#1721Pharmaceutical compositions with enhanced stability
#1722DEPOT COMPOSITIONS WITH MULTIPLE DRUG RELEASE RATE CONTROLS AND USES THEREOF
#1723Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1724Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
#1725Pharmaceutical formulations for sustained drug delivery
#1726PROCESSES FOR MAKING PARTICLE-BASED PHARMACEUTICAL FORMULATIONS FOR PARENTERAL ADMINISTRATION
#1727Biodegradable non-opthalmic implants and related methods
#1728STERILIZED NANOPARTICULATE GLUCOCORTICOSTEROID FORMULATIONS
#1729Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same
#1730Preparation of solid coprecipitates of amorphous valsartan
#1731Nanoparticulate and controlled release compositions comprising a cephalosporin
#1732Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#1733Solid ganaxolone formulations and methods for the making and use thereof
#1734Ion exchange resin treated to control swelling
#1735Pharmaceutical compositions of adsorbates of amorphous drug
#1736Nanoparticulate aripiprazole formulations
#1737Liquid ganaxolone formulations and methods for the making and use thereof
#1738Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
#1739Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
#1740Oral paracetamol formulations
#1741Pharmaceutical composition
#1742Ion exchange resin treated to control swelling
#1743Method for delivering hydrophobic drugs via nanocrystal formulations
#1744ZONISAMIDE AND NSAID NANOPARTICULATE FORMULATIONS
#1745COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#1746Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1747Nanoparticulate insulin
#1748Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1749Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1750Composition having liver function protecting effect
#1751Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1752Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1753Methods and compositions for treating proliferative diseases
#1754Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#1755Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
#1756Microparticles, microparticle production method, and microparticle production apparatus
#1757In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions
#1758Nanoparticulate tadalafil formulations
#1759Medicament sustained-release particles and method for preparing the same
#1760Methods of making and using novel griseofulvin compositions
#1761Particles shaped as platelets
#1762Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
#1763NON-BENZODIAZEPINE HYPNOTIC COMPOSITIONS
#1764Method of bioimaging using nanocrystals of fluorescent dyes
#1765Process for Preparing a Co-Precipitate of a Non-Crystalline Solid Drug Substance
#1766Particle size reduction of bioactive compounds
#1767Banded controlled release nanoparticle active agent formulation dosage forms and methods
#1768Composition improved in the solubility or oral absorbability
#1769Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
#1770Nanoparticulate ebastine formulations
#1771Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
#1772Ion exchange resin treated to control swelling
#1773Cross-linked polysacharide and protein matrices and methods for their preparation
#1774Coenzyme Q10-containing fine particle with excellent dispersibility
#1775Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
#1776Nanoparticulate anticonvulsant and immunosuppressive compositions
#1777Nanoparticulate benidipine compositions
#1778Controlled and Sustained Gene Transfer Mediated by Thiol-Modified Polymers
#1779Pharmaceutical composition for the treatment of acute disorders
#1780Nanoparticulate clarithromycin formulations
#1781Nanoparticulate clopidogrel formulations
#1782Coated particles for sustained-release pharmaceutical administration
#1783Nanoparticulate clopidogrel and aspirin combination formulations
#1784Amine polymer-modified nanoparticulate carriers
#1785Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion
#1786WATER SOLUBLE ANALGESIC FORMULATIONS AND METHODS FOR PRODUCTION
#1787Nanoparticulate acetaminophen formulations
#1788Lipophilic compositions
#1789Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
#1790Hybrid nanocrystals for treatment and bioimaging of disease
#1791Nanoparticulate imatinib mesylate formulations
#1792Method for producing water dispersible dry powders from poorly soluble compounds
#1793Pharmaceutical formulation
#1794Antifungal compositions with improved bioavailability
#1795Combinations and modes of administration of therapeutic agents and combination therapy
#1796Coated tablets
#1797Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
#1798Compositon useful for delivery of active agents
#1799Drug nano-particle, method and apparatus for preparing pharmaceutical preparation using the particle
#1800Oil-in-water method for making polymeric implants containing a hypotensive lipid